GlassScriptPhysician profile
Robert B Wai
NPI 1134181308
$14,434.22
in general payments reported to CMS, 2019-2025
34 companies · $8,848 in 2025
The $8,848 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $237 · 2021: $439 · 2022: $505 · 2023: $560 · 2024: $3,321 · 2025: $8,848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $1,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,400.00 |
| Food and Beverage | $1,328.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $11,400.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $543.18 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $383.84 | 2019-2024 | |
| Exeltis, USA INC. | $279.00 | 2019-2025 | Slynd |
| Biogen, INC. | $201.20 | 2024-2025 | Zurzuvae, Vumerity |
| Allergan, INC. | $172.99 | 2019-2020 | |
| Astellas Pharma US INC | $166.67 | 2022-2025 | Veozah, Myrbetriq |
| Organon LLC | $123.75 | 2022-2025 | Nexplanon |
| Minerva Surgical, INC | $99.62 | 2019-2024 | |
| Mylan Pharmaceuticals INC. | $96.23 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $94.21 | 2023-2024 | Myfembree |
| Lupin INC. | $83.07 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.79 | 2019-2024 | |
| Hologic Sales and Service, LLC | $67.26 | 2022-2025 | Fluent Fluid Management System, Acessa Provu System, Novasure |
| Mayne Pharma Commercial LLC | $65.08 | 2022-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $56.06 | 2022-2024 | Twirla |
| Duchesnay USA Incorporated | $47.71 | 2019-2020 | |
| Therapeuticsmd, INC. | $46.24 | 2019-2021 | |
| Avion Pharmaceuticals | $46.10 | 2019-2023 | Balcoltra |
| Scynexis, INC. | $45.65 | 2022 | |
| Shield Therapeutics INC | $42.31 | 2023 | Accrufer |
| Medtronic, INC. | $39.33 | 2022-2024 | Venaseal |
| Dilon Technologies, INC. | $36.97 | 2025 | Hemoblast Bellows |
| Gynesonics, INC. | $33.38 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Molnlycke Health Care US, LLC | $32.43 | 2024 | Mepilex Border Post-Op, Mepilex Border Post-Op Ag |
| Merck Sharp & Dohme LLC | $29.93 | 2019 | |
| Convatec INC. | $26.79 | 2023 | |
| Myovant Sciences INC. | $22.09 | 2022 | |
| Millicent US INC | $18.18 | 2024 | Intrarosa |
| Coopersurgical, INC. | $17.83 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.70 | 2020 | |
| Mallinckrodt Enterprises LLC | $12.31 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.31 | 2019 | |
| Channel Medsystems, INC. | $9.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.